BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
Cell & Gene Meeting on the Mesa 2026
October 5 - October 7
Advancing the Commercialization of Cell and Gene Therapies
The Cell & Gene Meeting on the Mesa is one of the premier annual conferences dedicated to advancing the commercialization of cell and gene therapies. Bringing together more than 1,500 industry leaders, investors, technology developers, manufacturers, and healthcare innovators, the event serves as a critical forum for addressing the challenges and opportunities shaping the future of advanced therapies.
The conference explores key topics including clinical development, manufacturing scale-up, supply chain readiness, regulatory strategy, reimbursement models, investment trends, and commercialization pathways. Through expert-led panels, company presentations, partnering meetings, and networking opportunities, attendees gain insights into the technologies and business models driving the next generation of therapies.
ARMI will attend Meeting on the Mesa 2026 to engage with leaders across the cell and gene therapy community, strengthen strategic partnerships, and participate in discussions focused on translating scientific innovation into scalable, commercially viable products. The event aligns closely with ARMI’s mission to accelerate the development and manufacturing of regenerative medicine technologies while strengthening domestic biomanufacturing capabilities.
Join industry leaders in Phoenix for three days of collaboration, networking, and discussion focused on bringing advanced therapies from development to widespread patient impact.
